Intervacc AB (publ)
SSE:IVACC.ST
3.73 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Intervacc AB (publ) |
Symbool | IVACC.ST |
Munteenheid | SEK |
Prijs | 3.735 |
Beurswaarde | 282,875,081 |
Dividendpercentage | 0% |
52-weken bereik | 3.315 - 12.681 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonas Sohlman |
Website | https://www.intervacc.se |
An error occurred while fetching data.
Over Intervacc AB (publ)
Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles. The company also markets and sells veterinary medicines; and provides diagnostic
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)